Enfusion Correlations
ENFN Stock | USD 9.30 0.03 0.32% |
The correlation of Enfusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enfusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enfusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Modest diversification
The correlation between Enfusion and NYA is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and NYA in the same portfolio, assuming nothing else is changed.
Enfusion |
The ability to find closely correlated positions to Enfusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enfusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enfusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enfusion to buy it.
Moving against Enfusion Stock
0.67 | DOMO | Domo Inc Financial Report 23rd of May 2024 | PairCorr |
0.65 | DT | Dynatrace Holdings LLC Sell-off Trend | PairCorr |
0.59 | WK | Workiva Financial Report 7th of May 2024 | PairCorr |
0.49 | U | Unity Software Financial Report 8th of May 2024 | PairCorr |
0.47 | QH | QuhuoLtd | PairCorr |
0.46 | PD | Pagerduty Financial Report 6th of June 2024 | PairCorr |
0.45 | EB | Eventbrite Class A Financial Report 14th of May 2024 | PairCorr |
0.45 | VCSA | Vacasa Inc Financial Report 14th of May 2024 | PairCorr |
0.43 | DMAN | Innovativ Media Group | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Enfusion Stock performing well and Enfusion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enfusion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
AI | 3.06 | (0.41) | 0.00 | (0.08) | 0.00 | 7.84 | 32.77 | |||
SHOP | 1.99 | (0.30) | 0.00 | (0.10) | 0.00 | 4.43 | 21.49 | |||
TTD | 2.04 | 0.24 | 0.11 | 0.21 | 2.24 | 4.15 | 24.62 | |||
ADSK | 1.25 | (0.25) | 0.00 | (0.12) | 0.00 | 2.44 | 8.24 | |||
INTU | 1.12 | (0.07) | (0.02) | 0.00 | 1.61 | 1.92 | 7.37 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Enfusion without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
All Next | Launch Module |
Enfusion Corporate Management
Elected by the shareholders, the Enfusion's board of directors comprises two types of representatives: Enfusion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enfusion. The board's role is to monitor Enfusion's management team and ensure that shareholders' interests are well served. Enfusion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enfusion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stephen Dorton | Chief Officer | Profile | |
Michael Berry | Chief Officer | Profile | |
Lorelei Skillman | Chief Officer | Profile | |
Stephen Malherbe | Managing Partner | Profile | |
Oleg Movchan | Interim Director | Profile | |
Bronwen Bastone | Chief Officer | Profile | |
Joseph Defeo | Global Production | Profile |
Already Invested in Enfusion?
The danger of trading Enfusion is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Enfusion is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Enfusion. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Enfusion is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.Note that the Enfusion information on this page should be used as a complementary analysis to other Enfusion's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Enfusion Stock analysis
When running Enfusion's price analysis, check to measure Enfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enfusion is operating at the current time. Most of Enfusion's value examination focuses on studying past and present price action to predict the probability of Enfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enfusion's price. Additionally, you may evaluate how the addition of Enfusion to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Enfusion's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share 0.07 | Revenue Per Share 1.979 | Quarterly Revenue Growth 0.147 | Return On Assets 0.0642 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.